Evaluation of the performance of potassium ion sensitive field effect transistors (K + ISFETs), developed by Thorn EMI in a form suitable for mass production and for incorporation in 'near the patient' analysers, showed only very small constant and proportional biases against the Radiometer KNA 1 and the Corning 902 for whole blood potassium ion estimation. Between batch imprecision tests with whole blood showed the K + ISFET was comparable in performance to the Corning 902 but inferior to the Radiometer KNA 1. The evaluation demonstrated that ISFET manufacturing technology has now reached a stage of development at which ISFETs should be considered seriously for use in clinical chemical analysers. FIG.
Evaluation of the performance of potassium ion sensitive field effect transistors (K + ISFETs), developed by Thorn EMI in a form suitable for mass production and for incorporation in 'near the patient' analysers, showed only very small constant and proportional biases against the Radiometer KNA 1 and the Corning 902 for whole blood potassium ion estimation. Between batch imprecision tests with whole blood showed the K + ISFET was comparable in performance to the Corning 902 but inferior to the Radiometer KNA 1. The evaluation demonstrated that ISFET manufacturing technology has now reached a stage of development at which ISFETs should be considered seriously for use in clinical chemical analysers. being measured. This is measured with respect to an external reference electrode. The electrodes are connected to a high impedance amplifier so that only a minute current of the order of picoamperes is drawn. Thus the potential measurement is made without significant distortion. Ion selective field effect transistors (ISFETs) have been used experimentally for cation measurement in whole blood by several groups!", both in vitro and in vivo. Previously, such devices have generally not been suitable for large-scale manufacturing (in the range of hundreds of thousands or millions of devices per year). This may be inferred from the absence of commercially available instruments incorporating ISFETs, despite reports in the literature dating back to 1970 4 . Until now, the deposition of the electro active membrane and the encapsulation materials have been performed manually by a skilled technician. Recently, however, Thorn EMI have made claims relating to specific advances in electroactive films and associated deposition and patterning techniques suitable for volume production and encapsulation of ISFET sensors, together with on-chip signal processing (D Pedley and P Whalley, personal communication). These manufacturing techniques are now undergoing detailed tests prior to establishing a dedicated manufacturing facility.
With conventional ion selective electrodes the measurement system may be represented as in Fig. 1 , in which the potential difference of interest is that which is produced across the ion selective membrane between the inner 'reference' solution inside the ion selective electrode and the solution Correspondence: Dr 1 M Thompson. tory ion-selective electrode (ISE) analysers (the Radiometer KNAl and the Corning 902). Tests were performed using both commercial quality control materials and whole blood samples from patients chosen to provide a wide range of values of potassium ion concentrations.
Materials and methods

CALIBRANTS
The cali brant buffers relied for their buffering capacity on the use of the organic buffers: 3-(Nmorpholino)propane sulphonic acid (MOPS) and N-2-(hydroxyethyl)piperazine-N-ethane sulphonic acid (HEPES). The baseline calibrant was a MOPS-based buffer which contained 2 mM potassium and the slope cali brant was a HEPES-based buffer containing 7 mM potassium. Both buffers INSTRUMENTS AND SENSORS A K + ISFET was used which was from a production batch of K + ISFETs (Thorn EMI Microsensors, Hayes, Middlesex, UK) mounted in a dual-in-line configuration and fitted with a flow cell. A drawing of the mounted ISFET with its flow cell is shown in Fig. 4 . The ISFET was fitted to a Thorn EMI Microsensors ISM-100 ion-selective monitor.
Analogue recordings were made of ISFET responses using a Brown-Boveri Goerz Metrawatt SEI20 recorder with full scale deflection set at 100 mY and chart speed at 10 mm/min, The introduction of samples of whole blood or serum was preceded and followed by an air bubble, which helped to clear each sample from the flow cell. Between each sample, a baseline calibrant/ wash buffer was flushed through the system and baseline drift checked. Slope calibrant buffer was introduced after each set of replicates to check slope stability. A typical recording showing the responses oftwo K + ISFETs on the same 'chip' to the two calibrant buffers and to whole blood is shown in Fig. 5 .
Millivolt readings from the analogue recordings were taken at 20 s intervals after the introduction of each blood/serurn/calibrant sample into the flow cell. Potassium ion concentrations were determined graphically by interpolation of log/linear plots of the ISFET response to the two calibrant buffers. Conventional ISE analysers used in the trial were a Corning 902 (Ciba-Corning Diagnostics, Halstead, UK) and a Radiometer KNAI (Radiometer UK, Ltd, Crawley, West Sussex, UK). All the instruments were in close proximity while blood samples were being tested. Coated wire electrodes have evolved by omission of the inner 'reference' solution (see Fig. 2 ). The electrodes are connected to a high impedance amplifier as with conventional ISEs and so the principles of operation remain the same.
In the case of ISFETs, the low impedance connecting wires linking the electrodes to the high impedance amplifier have disappeared as the field effect transistor (FET) is in direct contact with the ion selective membrane (Fig. 3 ). The FET acts as a high impedance amplifier with a low impedance output, so the whole of the early stage of potential measurement has been miniaturised and resides within the FET structure itself.
Potassium ISFETs, from two separate production batches which were manufactured using these techniques by Thorn EMI, have been tested by the authors and compared against two labora- Table I. heparinized 5 ml syringes from arterial manometer lines connected to patients in the intensive therapy unit or from patients in the operating theatre undergoing surgery on the heart or major blood vessels or for liver transplantation. The heparin used was calcium titrated (2100 IU/ml, supplied by Ciba-Corning Diagnostics, Halstead, UK). All samples were collected for routine patient management. A series of replicate whole blood samples was measured in order to estimate between run imprecision. Either two or three samples of blood were collected from the patient at the time of sampling for replication purposes. The individual variances for each set of replicates were combined in the standard way to obtain the overall variance." The equation describing the combination ofvariances is as follows: replicates, nl, n». ... nk are the numbers of observations in each of the k sets of replicates and N is the total number of observations in the series. This variance was used to calculate the standard deviation used in the calculation of the coefficient of variation.
Another series ofduplicate samples was used to estimate within batch analytical imprecision. The analytical imprecision was calculated using oneway analysis of variance from which the estimate was obtained of the analytical error. The standard deviation thus obtained was used to calculate the coefficient of variation. This second series was performed on another ISFET from a second production run.
QUALITY CONTROL MATERIALS
'NOVA Stat Control (A)' materials (manufactured by Nova Biomedical, Laufelfingen, Switzerland) were used in a separate trial of the ISFETs and the Radiometer and Corning analysers. The materials were specifically developed for ISE quality assurance. Three types are available providing low, normal and high levels of various ions. These materials are ready-to-use liquid control materials designed to mimic the properties of human serum when assayed for the constituents listed in the assay data tables supplied with each lot (manufactured batch). The manufacturer's data on the potassium ion concentrations in each level of the supplied batches is shown in Table Table 2 lists the within batch imprecision data obtained from the tests with the NOVA materials. The Corning 902 performed best in these tests. The Radiometer KNAI performed similarly to the Corning with the normal and high level materials but it gave a coefficient of variation for the low level material which was about three times that obtained with the normal level material. The ISFETs gave coefficients of variation about 2'5-3 times those obtained with the Corning 902.
IMPRECISION TESTS WITH WHOLE BLOOD
The between batch imprecision tests performed using replicate samples of whole blood are shown in Table 3 . The Radiometer KNAI, although it had greater imprecision than with the control materials, was still performing well within the bounds of acceptibility recently proposed by Fraser" and Buckley and Broughton."
The imprecision of the ISFET was marginally outside the bounds suggested by Fraser," as was that of the Corning 902, but both could be regarded as producing results which are clinically acceptable according the criteria discussed by Skendzel et al., 12 who suggest on the basis of a consensus of physicians' opinions that a CV for serum potassium of 4·8% would be reasonable. It is interesting to note that the Corning 902 performed better than the Radiometer KNA I using the NOVA materials but that their performances relative to one another were reversed with whole blood. This raises questions about the usefulness of quality assurance materials in evaluations of this kind.
Testing an additional ISFET device from a separate ISFET production run with whole blood (nine sets of duplicate samples each measured three times) produced a within batch coefficient of variation of 3·58%. This is an encouraging set of results in terms of the potential application of these ISFETs in 'near the patient' systems.
COMPARISONS USING WHOLE BLOOD
Least squares linear regression analysis of the results of the large series of tests on blood samples measured on all the systems is summarised in 
Conclusions
The tests with whole blood were considered more important than those with the control materials because measurements in whole blood represent the principal application of 'near the patient' systems such as these. Because of differences in the matrices of serum, plasma, the various quality controls and whole blood, it was considered that resistant line regression method available in Minitab.P-" Using this procedure, no assumptions are made about whether the independent variable is error free and, in fact, it is assumed that errors are present in both x and y. The procedure is nonparametric (that is, it makes no assumptions about the data distribution) and it is resistant to wild data. The three group resistant line regression estimates are included in Table 4 for comparison. These estimates are not vastly different from the least squares estimates, so that we may conclude that the latter are not unreasonable. The regressions show that there were only very small constant and proportional biases between the Thorn EMI ISFET, the Radiometer KNAI and the Corning 902 and that the correlation coefficients relating the three measurement systems were all high and similar. This may be regarded as further evidence that the ISFET technology has now reached a sufficiently advanced stage of development to be worthy of incorporation in 'near the patient' analysers. Table 4 and illustrated in Figs. 6-8. The regressions performed assume, as is usual in least squares regression, that the independent variable (the x values) is error free. Although this is standard practice in such clinical evaluations, this has been criticised in the past"-" and it has been suggested that alternative regression procedures should be used. The reliability of the regression estimates was checked using the three group these would affect the various sensors in ways which are not yet understood. Thus it would be difficult to relate performance of a sensor with whole blood to its performance with these other test materials in a meaningful manner. There may be several reasons for such matrix differences, including differences in the types and amounts of proteins and other materials adsorbed onto the sensor membrane and at the reference electrode liquid junction and the influence such adsorbed layers would have on the electric double layer compositions and, consequently, on the interfacial zeta potentials. The imprecision tests and comparisons with conventional ISE technology demonstrate that it is now possible, with these improved fabrication techniques and materials specifications, to produce K + ISFETs in a reliable and reproducible manner for specific ion activity measurements in whole blood. It is understood from Thorn EMI Microsensors that the ISFETs will be incorporated into a multiple-test cartridge system with built-in calibrants enabling regular baseline and periodic slope checks to be made. This is more likely to provide an acceptable level of quality control of the measurement process than could be ever achieved with a single test card system.
